← DR REDDYS LABORATORIES LTD

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 TTM
Cash flows from operating activities:
Net Income — — — — — — $45.1b
$55.7b +23.56%
$56.5b +1.54%
$42.9b -24.22%
$32.7b -23.65%
Net Income From Continuing Operations — — — — — — $45.1b $55.7b $57.2b $42.5b $32.7b
Profit or Loss — $151.0m $272.0m $259.0m $236.0m $311.0m $548.0m $668.0m $671.0m — —
Depreciation and amortization $11.3b $11.7b $176.0m $165.0m $175.0m $156.0m $154.0m $178.0m $200.0m $220.0m $21.2b
Amortization Cash Flow — — — — — — — $5.3b $6.6b $8.0b —
Amortization Of Intangibles — — — — — — — $5.3b $6.6b $8.0b $8.1b
Depreciation Amortization Depletion — — — — — — $12.6b $14.8b $17.1b $20.6b $21.2b
Deferred Income Tax — — — — — — $15.3b $16.2b $19.5b $12.4b $8.6b
Deferred Tax — — — — — — $15.3b $16.2b $19.5b $12.4b $8.6b
Adjustments For Share-Based Payments — $7.0m $6.0m $7.0m $8.0m $8.0m $5.0m $5.0m $5.0m — —
Equity settled share-based payment expense $350.0m $454.0m $6.0m $7.0m $8.0m $8.0m $5.0m $5.0m $5.0m $3.0m —
Impairment of non-current assets, net $445.0m $53.0m $3.0m $222.0m $117.0m $100.0m $9.0m $1.0m $20.0m $38.0m —
Asset Impairment Charge — — — — — — $5.6b $3.6b $6.9b $11.0b $12.9b
Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method — $984.0m $1.1b $1.5b $1.1b $1.0b $1.4b $1.6b $3.3b — —
Earnings (Loss)es From Equity Investments — — — — — — ($370.0m) ($147.0m) ($217.0m) ($134.0m) ($140.0m)
Change In Working Capital — — — — — — ($7.9b) ($20.2b) ($30.0b) ($11.6b) ($15.4b)
Allowance for credit losses (on trade receivables and other advances) — $155.0m $420.0m $3.0m $3.0m $1.0m $2.0m $3.0m $2.0m $8.0m —
Trade and other receivables $3.0b ($2.1b) $26.0m ($165.0m) $28.0m ($224.0m) ($70.0m) ($97.0m) ($120.0m) ($72.0m) —
Change In Receivables — — — — — — ($5.8b) ($8.1b) ($10.3b) ($6.7b) ($342.0m)
Changes In Account Receivables — — — — — — — — ($10.3b) ($6.7b) ($342.0m)
Inventories write-down $3.1b $2.9b $4.0b — $2.5b $4.6b $59.0m $43.0m $61.0m $80.0m —
Inventories ($6.3b) ($3.2b) ($123.0m) ($20.0m) ($135.0m) ($70.0m) ($32.0m) ($221.0m) ($149.0m) ($92.0m) ($9.7b)
Change In Inventory — — — — — — ($2.7b) ($18.4b) ($12.8b) ($8.6b) ($9.7b)
Trade and other payables $1.9b $2.5b $6.0m $21.0m $39.0m $58.0m $0 $42.0m $4.0m $30.0m —
Other assets and other liabilities, net ($3.9b) ($6.1b) $8.0m $64.0m ($45.0m) $53.0m $6.0m $34.0m ($85.0m) $11.0m —
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $44.0m $2.0m $18.0m $2.0m $1.0m $5.0m $1.0m $13.0m $6.0m $3.0m —
Purchase of property, plant and equipment ($12.3b) ($9.3b) ($101.0m) ($64.0m) ($133.0m) ($193.0m) ($138.0m) ($197.0m) ($322.0m) ($249.0m) —
Capital Expenditure Reported — — — — — ($19.0b) ($18.9b) — — — ($32.0b)
Purchase of other investments (including bank deposits) ($49.7b) ($68.4b) ($1.1b) ($1.5b) ($1.0b) ($1.2b) ($1.7b) ($1.7b) ($3.0b) ($498.0m) —
Proceeds from sale of other investments (including bank deposits) $71.6b $64.0b $1.1b $1.5b $1.1b $1.0b $1.4b $1.6b $3.3b $209.0m —
Net cash used in investing activities ($18.5b) ($14.9b) ($112.0m) ($65.0m) ($310.0m) ($348.0m) ($503.0m) ($483.0m) ($682.0m) ($700.0m) ($42.5b)
Cash flows from financing activities:
Proceeds From Borrowings Classified As Financing Activities — $66.6b $42.9b $29.8b $48.3b $51.5b $49.2b $19.4b $80.6b — —
Repayments Of Borrowings Classified As Financing Activities — $65.7b $58.1b $48.5b $41.4b $48.0b $68.6b $13.9b $56.2b — —
Proceeds from/(repayment of) short-term borrowings, net $21.5b ($18.0b) ($219.0m) $56.0m $93.0m $3.5b ($236.0m) $66.0m $287.0m $215.0m —
Proceeds from long-term borrowings (Refer to Note 16 for details) — — — — $52.0m $0 $0 $46.0m $0 $0 —
Repayment of long-term borrowings (Refer to Note 16 for details) — — — ($22.9b) ($51.0m) $0 $0 ($46.0m) $0 $0 —
Issuance Of Debt — — — — — — $0 $3.8b $0 $0 $0
Long Term Debt Issuance — — — — — — $0 $3.8b $0 $0 $0
Net Issuance Payments Of Debt — — — — — — ($20.4b) $4.3b $23.2b $19.0b $13.4b
Net Long Term Debt Issuance — — — — — — ($1.0b) ($1.1b) ($1.3b) ($1.3b) ($5.0b)
Net Short Term Debt Issuance — — — — — $3.5b ($19.4b) $5.5b $24.5b $20.3b $18.5b
Long Term Debt Payments — — — — — — ($1.0b) ($4.9b) ($1.3b) ($1.3b) ($5.0b)
Repayment Of Debt — — — — — — ($1.0b) ($4.9b) ($1.3b) ($1.3b) ($5.0b)
Issuance Of Capital Stock — — — — — — $368.0m $805.0m $193.0m $397.0m $449.0m
Repurchase Of Capital Stock — — — — — — $0 $0 ($1.4b) $0 $0
Common Stock Issuance — — — — — — $368.0m $805.0m $193.0m $397.0m $449.0m
Common Stock Payments — — — — — — $0 $0 ($1.4b) $0 $0
Dividends paid — $4k $4k $4k $4k $4k $5k $7k $7k — ($6.7b)
Dividends Paid Classified As Financing Activities — $61 $58 $52 $57 $55 $61 $80 $78 — ($6.7b)
Dividends Paid Ordinary Shares Per Share — $20.00 $20.00 — — — — — — — ($6,659,000,000.00)
Dividend income — $0 $0 $0 $0 $0 $0 $0 $0 $0 —
Dividends received from equity accounted investees — $0 $0 $5.0m — $0 $0 $5.0m $0 $0 —
Interest and dividend received $628.0m $412.0m $11.0m $8.0m $17.0m $12.0m $9.0m $16.0m $38.0m $16.0m —
Dividend paid ($3.4b) ($4.0b) ($58.0m) ($52.0m) ($57.0m) ($55.0m) ($61.0m) ($80.0m) ($78.0m) ($71.0m) —
Cash Dividends Paid — — — — — — ($5.0b) ($6.6b) ($6.7b) ($6.7b) ($6.7b)
Dividends Received CFI — — — — — — $0 $445.0m $0 $0 $0
Net cash from/(used) in financing activities ($3.7b)
($4.4b) -20.26%
($308.0m) +93.06%
($334.0m) -8.44%
($4.0m) +98.80%
($32.0m) -700.00%
($327.0m) -921.88%
($45.0m) +86.24%
$222.0m +593.33%
$88.0m -60.36%
—
Net increase/(decrease) in cash and cash equivalents ($650.0m) ($1.3b) ($5.0m) ($3.0m) $174.0m ($9.0m) ($114.0m) $17.0m $85.0m ($5.0m) —
Beginning Cash Position — — — — — — $14.9b $5.8b $7.1b $14.6b $9.0b
Cash and cash equivalents at the beginning of the year $3.8b $2.5b $2.2b $2.0b $14.8b $196.0m $70.0m $85.0m $171.0m $164.0m —
Effect of exchange rate changes on cash and cash equivalents ($492.0m) $57.0m $1.0m $0 $113.0m $10.0m $3.0m ($1.0m) $1.0m $13.0m $1.1b
Effect Of Exchange Rate Changes — — — — — — $286.0m ($59.0m) $224.0m $1.2b $1.1b
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Adjustments For Income Tax Expense — $70.0m $53.0m ($19.0m) $125.0m $115.0m $186.0m $194.0m $229.0m — —
Interest (income)/expense, net $76.0m $248.0m $2.0m $1.0m $2.0m $0 $3.0m ($7.0m) $2.0m $0 —
Additional Financial Items
Adjustments For Unrealised Foreign Exchange Losses Gains — ($5.0m) ($23.0m) ($29.0m) $25.0m ($10.0m) ($11.0m) ($6.0m) $2.0m — —
Goodwill — $61.0m $56.0m $53.0m $62.0m $58.0m $52.0m $51.0m $138.0m — $12.9b
Payments To Acquire Or Redeem Entitys Shares — $0 $0 — — $0 — — — — —
Proceeds From Issuing Shares — $0 $0 — — — — — — — —
Purchase Of Intangible Assets Classified As Investing Activities — $27.0m $8.0m $17.0m $39.0m $58.0m $92.0m $132.0m $81.0m — —
Profit for the year $12.0b $9.8b $272.0m $259.0m $17.2b $311.0m $548.0m $668.0m $671.0m $452.0m —
Tax expense, net $2.6b $4.5b $53.0m ($19.0m) $125.0m $115.0m $186.0m $194.0m $229.0m $132.0m —
Fair value changes and profit on sale of financial instruments measured at FVTPL, net — — — ($929.0m) ($557.0m) ($4.0m) ($11.0m) ($38.0m) ($42.0m) ($25.0m) —
(Profit)/ Loss on sale/disposal of assets, net — — — $68.0m $42.0m ($15.0m) $3.0m ($11.0m) ($18.0m) ($27.0m) —
Share of profit of equity accounted investees ($349.0m) ($344.0m) ($6.0m) ($7.0m) ($7.0m) ($9.0m) ($5.0m) ($2.0m) ($3.0m) ($1.0m) —
Unrealized exchange (gain)/loss, net $609.0m ($296.0m) ($23.0m) ($29.0m) $25.0m ($10.0m) ($11.0m) ($6.0m) $2.0m ($6.0m) —
Cash generated from operations $27.3b
$20.8b -23.80%
$485.0m -97.67%
$490.0m +1.03%
$566.0m +15.51%
$468.0m -17.31%
$847.0m +80.98%
$786.0m -7.20%
$779.0m -0.89%
$751.0m -3.59%
—
Purchase of other intangible assets ($28.7b) ($1.8b) ($8.0m) ($17.0m) ($39.0m) ($58.0m) ($92.0m) ($132.0m) ($81.0m) ($161.0m) —
Proceeds from sale of other intangible assets — $0 $885.0m $3.0m $0 $39.0m $0 $1.0m $9.0m $15.0m —
Payment for acquisition of businesses ($17.0m) $0 $0 — ($15.5b) ($4.0m) $0 $0 ($622.0m) ($34.0m) —
Investment in associates ($86.0m) $0 $0 — — $0 $0 ($1.0m) ($4.0m) ($1.0m) —
Proceeds from issuance of equity shares (including treasury shares) $1.0m $1.0m $0 $0 $269.0m $4.0m $2.0m $10.0m $2.0m $4.0m —
Purchase of treasury shares $0 $0 ($8.0m) ($6.0m) ($16.0m) $0 $0 $0 ($16.0m) $0 —
Proceeds from issuance of equity shares in subsidiary comprising NCI (Refer to Note 35.A for details) — — — — — — $0 $0 $83.0m $0 —
Payment of principal portion of lease liabilities (Refer to Note 16 for details) — ($157.0m) ($56.0m) ($6.0m) ($754.0m) ($10.0m) ($12.0m) ($14.0m) ($15.0m) ($13.0m) —
Cash Flow From Continuing Financing Activities — — — — — — ($26.9b) ($3.8b) $18.9b $8.3b $2.4b
Cash Flow From Continuing Investing Activities — — — — — — ($41.4b) ($40.3b) ($58.1b) ($65.5b) ($42.5b)
Change In Account Payable — — — — — — — — $340.0m $2.8b $2.8b
Change In Other Working Capital — — — — — — $528.0m $2.9b ($7.3b) $897.0m ($6.3b)
Change In Payable — — — — — — $23.0m $3.5b $340.0m $2.8b $2.8b
Changes In Cash — — — — — — ($9.4b) $1.4b $7.3b ($468.0m) $1.1b
End Cash Position — — — — — — $5.8b $7.1b $14.6b $15.4b $10.1b
Financing Cash Flow — — — — — — ($26.9b)
($3.8b) +85.99%
$18.9b +602.55%
$8.3b -56.16%
$2.4b -71.34%
Free Cash Flow — — — — — — $40.0b $18.0b $12.0b $18.3b $9.2b
Interest Received CFI — — — — — — $777.0m $1.3b $3.4b $1.5b $2.1b
Investing Cash Flow — — — — — — ($41.4b) ($40.3b) ($58.1b) ($65.5b) ($42.5b)
Net Business Purchase And Sale — — — — — — $0 ($12.0m) ($53.4b) ($3.2b) ($3.4b)
Net Foreign Currency Exchange Gain Loss — — — — — — ($939.0m) ($534.0m) $211.0m ($529.0m) ($2.1b)
Net Intangibles Purchase And Sale — — — — — — ($7.5b) ($11.0b) ($6.2b) ($13.7b) ($8.6b)
Net PPE Purchase And Sale — — — — — — ($11.2b) ($15.3b) ($27.0b) ($23.0b) ($19.3b)
Operating Gains Losses — — — — — — ($1.1b) ($1.6b) ($1.5b) ($3.2b) ($5.2b)
Other Non Cash Items — — — — — — $248.0m ($567.0m) $152.0m $12.0m —
Provisionand Write Offof Assets — — — — — — $205.0m $275.0m $161.0m $690.0m $550.0m
Purchase Of Business — — — — — — $0 ($12.0m) ($53.4b) ($3.2b) ($3.4b)
Purchase Of Intangibles — — — — — — ($7.5b) ($11.0b) ($6.9b) ($15.1b) ($12.1b)
Purchase Of PPE — — — — — — ($11.3b) ($16.4b) ($27.5b) ($23.3b) ($32.0b)
Sale Of Intangibles — — — — — — $0 $21.0m $732.0m $1.4b $3.5b
Sale Of PPE — — — — — — $82.0m $1.1b $512.0m $309.0m $633.0m
Stock Based Compensation — — — — — — $397.0m $407.0m $424.0m $326.0m $311.0m
Unrealized Gain Loss On Investment Securities — — — — — — ($876.0m) ($3.1b) ($3.6b) ($2.4b) ($2.7b)
Net Investment Purchase And Sale — — — — — — ($23.4b) ($15.7b) $25.1b ($27.1b) ($13.4b)
Purchase Of Investment — — — — — — ($136.2b) ($41.6b) ($28.5b) ($46.7b) ($46.3b)
Sale Of Investment — — — — — — $112.8b $25.9b $53.6b $19.6b $33.0b
Change In Cash Supplemental As Reported — — — — — — ($9.4b) $1.4b $7.3b ($468.0m) —
Interest Paid Classified As Financing Activities ($925.0m) $20.0m $23.0m $21.0m $18.0m $18.0m $23.0m $27.0m $41.0m ($47.0m) —
Income tax paid, net ($5.8b) ($2.8b) ($70.0m) ($94.0m) ($78.0m) ($98.0m) ($130.0m) ($241.0m) ($234.0m) ($144.0m) —

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.